Olmesartan-induced enteropathy: More than one entity?
Eur J Intern Med
.
2022 Nov:105:113.
doi: 10.1016/j.ejim.2022.06.025.
Epub 2022 Jul 5.
Authors
Giuseppe Famularo
1
,
Andrea Aglitti
2
,
Laura Magrini
2
Affiliations
1
Internal Medicine, San Camillo Hospital, Rome, Italy. Electronic address: gfamularo@scamilloforlanini.rm.it.
2
Internal Medicine, San Camillo Hospital, Rome, Italy.
PMID:
35798591
DOI:
10.1016/j.ejim.2022.06.025
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Imidazoles / adverse effects
Intestinal Diseases* / chemically induced
Tetrazoles* / adverse effects
Substances
olmesartan
Tetrazoles
Imidazoles